Development of hyperthyroidism during long term interferon therapy in a patient with chronic myelogenous leukemia: Case report

Endocrine Journal

Volumn 44, Issue 5, 1997, Pages 715-717

  Özet, Ahmet ^a   Özet, Gülsüm ^a   Çalişkaner, Zafer ^a   Kömürcü, Şeref ^a   Öztürk, Bekir ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Hyperthyroidism; Interferon; Leukemia

Indexed keywords

ALPHA INTERFERON;

ADULT; ANXIETY; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DYSPNEA; FEMALE; HEART PALPITATION; HUMAN; HYPERTHYROIDISM; THYROID FUNCTION; WEIGHT REDUCTION;

EID: 0031448896     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.44.715     Document Type: Article

References (10)

1. Tsukada K, Nomura T, Higashi K, Takeuchi T (1994) Thyroid function abnormalities during Interferon therapy. Nippon Rinsho 52: 1895-1990.
2. Weissel M, Templ E, Gisslinger H (1995) Interferon-alpha-induced disorders of thyroid function. A retrospective analysis of the literature and personal experiences. Acta Med Austriaca 22: 1-5.
3. Baudin E, Marcellin P, Pouteau M, Colas Linhart N, Le Floch JP, Lemmonier C, Benhamou JP, Bok B (1993) Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol Oxf 39: 657-661.
4. Okanoue T, Sakamoto S, Yausi K, Takami S, Enjo F, Kashima K, Nakagawa Y, Tada H, Kanaoka H, Ohta M, et al. (1994) Side effects of interferon on endocrine and respiratory system in 545 cases of chronic hepatitis C. Nippon Shokakibyo Gakkai Zasshi 91: 995-1002.
5. Koizumi S, Mashio Y, Mizuo H, Matsuda A, Matsuya K, Mizumoto H, Ikota A, Beniko M, Iriuda Y (1995) Graves' hyperthyroidism following transient thyrotoxicosis during interferon therapy for chronic hepatitis type C. Intern Med 34: 58-60.
6. Chedin P, Chanson P, Duranteau L, Guilausseau PJ, Lubetzki J (1994) Dysthyroidism in patients treated with interferon alpha. Presse Med 23: 1659-1663.
7. Kalkner M, Hagberg H, karlsson-Parra A (1991) Autoantibody occurrence in hairy cell leukemia during prolonged interferon treatment. Eur J Haematol 45: 233-234.
8. Schilling P, Kursrock R, Kantarjian H, Gutterman J, Talpaz M (1991) Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 68: 1526-1537.
9. Vallisa D, Cavanna L, Berté R, Merli F, Ghisoni F, Buscarini L (1995) Autoimmune thyroid dysfunctions in hematologic malignancies treated with alpha-interferon. Acta Haematol 93: 31-35.
10. Roti E, Minelli R, Guiberti T, et al. (1996) Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med 101: 482-487.